Growth hormone secretion in primary degenerative dementia: Correlations with cognitive impairment

International Journal of Geriatric Psychiatry

Volumn 11, Issue 10, 1996, Pages 907-913

  Di Paolo, Enrica ^a   Zerbi, Francesco ^a   Porro, Sabino ^a   Tosca, Pietro ^a   Costelli, Patrizia ^b   Murialdo, Giovanni ^b,c   Fonzi, Stefano ^b   Solinas, Gian Piero ^b   Parodi, Cristina ^b   Gianelli, Maria Vittoria ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Alzheimer's disease; Cholinergic transmission; Dementia; Growth hormone; Growth hormone releasing hormone; Memory function

Indexed keywords

BRAIN PEPTIDE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; NEUROTRANSMITTER; PYRIDOSTIGMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEMENTIA; DISEASE SEVERITY; FEMALE; GROWTH HORMONE RELEASE; HORMONE RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEMORY; RATING SCALE;

EID: 10244244977     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(199610)11:10<907::AID-GPS410>3.0.CO;2-F     Document Type: Article

References (40)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. APA, Washington, DC.
2. Baddeley, A., Logic, R., Bressi, S., Dellia Sala, S. and Spinnler, H. (1986) Dementia and working memory. Quart. J. Exp. Psychol. 38A, 603-618.
3. Banki, C. M., Karmacsi, L., Bissette, G. and Nemeroff, C. B. (1992) Cerebrospinal fluid neuropeptides in dementia. Biol. Psychiat. 32, 452-456.
4. Bartus, R. T., Dean, R. L. III, Beer, B. and Lippa, A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-417.
5. Bondi, M. W., Salmon, D. P. and Butters, N. (1994) Neuropsychological features of memory disorders in Alzheimer disease. In Alzheimer Disease (R. D. Terry, R. Katzman and K. L. Bick, Eds). Raven Press, New York, pp. 41-63.
6. Cacabelos, R., Niigawa, H., Ikemura, Y., Yanagy, Y., Tanaka, S., Rodriguez-Arnao, M. D., Gomez-Pan, A. and Nishimura, T. (1988) GHRH-induced GH response in patients with senile dementia of the Alzheimer type. Acta Endocrinol. (Copenh.) 117, 295-301.
7. Candy, J. M., Gascoigne, A. D. and Biggins, J. A. (1985) Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. J. Neurol. Sci. 71, 315-323.
8. Caulfield, M. P., Straughan, D. W., Cross, A. J., Crow, T. and Birdsall, N. J. M. (1982) Cortical muscarinic receptor subtypes and Alzheimer's disease. Lancet ii, 1277.
9. Christie, J. E., Whally, L. J., Dick, B. H., Blackburn, I. M., Blackwood, D. H. R. and Fink, G. (1987) Characteristic plasma hormone changes in Alzheimer's disease. Brit. J. Psychiat. 150, 674-681.
10. Corpas, E., Mitchell Harman, S. and Blackman, M. C. (1993) Human growth hormone and human aging. Endocr. Rev. 14, 20-39.
11. Counts, D. R., Gwirtsman, H., Carlson, L. M. S., Lesem, M. and Cutler, G. B. Jr (1992) The effects of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J. Clin. Endocrinol. Metab. 75, 762-767.
12. Davidson, M., Davies, B. M., Bastiaens, L., Macaluso, J., Aryan, M., Ryan, T. and Davis, K. L. (1988) Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects. Am. J. Psychiat. 145, 1007-1009.
13. Davies, P., Katzman, R. and Terry, R. D. (1980) Reduced somatostatin-like immunoreativity in cerebral cortex from cases of Alzheimer's disease and Alzheimer type dementia. Nature 288, 279-280.
14. Davies, P., Levy, M. I., Rosenberg, G. S., Mathe, A. and Davies, K. (1982) Relationship between GH and cortisol and acetylcholine. A possible neuroendocrine strategy for assessing a cholinergic defect. In Alzheimer's Disease: Report on Progress in Research (S. Corkin, K. L. Davies, J. H. Growdon, E. Usdin and J. Wurtman, Eds). Raven Press, New York, pp. 204-210.
15. Deklosky, S. T., Harbaugh, R. E., Schmitt, F. A., Bakay, R. A., Chui, H. C., Knopman, D. S., Reeder, T. M., Shelter, A. G., Senter, A. J. and Markesbery, W. R. (1992) Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological and cognitive correlates. Ann. Neurol. 32, 625-632.
16. Doiraswamy, P. M., Krishnan, K. R. K. and Nemeroff, C. B. (1991) Neuropeptides and neurotransmitters in Alzheimer's disease: Focus on corticotropin releasing factor. Bailliere's Clin. Endocrinol. Metab. 5.1, 59-77.
17. Folstein, M. F., Folstein, S. E. and McHughes, P. R. (1975) Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psychiair. Res. 12, 189-198.
18. Franceschi, M., Perego, L., Felini-Strambi, L., Smirne, S. and Canal, N. (1988) Neuroendocrinological function in Alzheimer's disease. Neuroendocrinology 48, 367-370.
19. Geula, C. and Mesulam, M. M. (1994) Cholinergic system and related neuropathological predilection pattern in Alzheimer disease. In Alzheimer Disease (R. D. Terry, R. Katzman and K. L. Bick, Eds). Raven Press, New York, pp. 263-291.
20. Ghigo, E., Goffi, S., Arvat, E., Nicolosi, M., Procopio, M., Bellone, J., Imperiale, E., Mazza, E., Baracchi, G. and Camanni, F. (1990) Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging. Acta Endocrinol. (Copenh.) 123, 169-174.
21. Ghigo, E., Nicolosi, M., Arvat, E., Marcone, A., Danelon, F., Mucci, M., Franceschi, M., Smirne, S. and Camanni, F. (1993) Growth hormone secretion in Alzheimer's Disease: Studies with growth hormone-releasing hormone alone and combined with pyridostigmine or arginine. Dementia 4, 315-320.
22. Hachinski, V. C., Iliff, I. D. and Zilhka, E. (1975) Cerebral blood flow in dementia. Arch. Neurol. 32, 632-637.
23. Hasselmo, M. E. and Bower, J. M. (1993) Acetylcholine and memory. Trends Neurosci. 16, 218-222.
24. Hughes, C. P., Berg. L., Danzinger, W. C., Coben, L. A. and Martin, R. L. (1982) A new clinical scale for the staging in dementia. Brit. J. Psychiat. 140, 565-572.
25. Ishii, T. (1966) Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol. 6, 181-187.
26. Kelijman, M. and Frohman, L. A. (1988) Responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. J. Clin. Endocrinol. Metab. 66, 489-494.
27. Kitano, S., Morimoto, S., Fukuo, K., Miya, K., Yasuda, O., Koh, E., Hirotani, A., Nakahashi, T., Tamatani, M. and Ogihara, T. (1992) Circulating suppressing factor for the muscarinic acetylcholine receptor in patients with senile dementia of the Alzheimer type. Gerontology 38 (Suppl. 1) 24-28.
28. Lamperti, E., Cocchi, D., Parati, E. A., Caraceni, T. and Müller, E. E. (1992) Growth hormone responses to cholinergically active drugs in patients with dementia of the Alzheimer type. Alzheimer Dis. Assoc. Disord. 6, 44-52.
29. Locatelli, V., Torsello, A., Redaelli. M., Ghigo, E., Massara, F. and Müller, E. E. (1986) Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone releasing hormone in the rat: Evidence for mediation by somatostatin. J. Endocrinol. 111, 271-278.
30. Mururialdo, G., Fonzi, S., Torre, F., Costelli, P., Solinas, G. P., Tosca, P., Di Paolo, E., Porro, S., Zerbi, F. and Polleri, A. (1993) Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing on the pituitary-adrenal axis and on growth hormone secretion in dementia. Neuropsychobiology 28, 177-183.
31. Murialdo, G., Zerbi, F., Filippi, U., Tosca, P., Fonzi, S., Di Paolo, E., Costelli, P., Porro, S., Polleri, A. and Savoldi, F. (1990-91) Cholinergic modulation of growth hormone-releasing hormone on growth hormone secretion in dementia. Neuropsychobiology 24, 129-134.
32. Nemeroff, C. B., Krishnan, K. R. R., Belkin, B. M., Ritchie, J. C., Clark, C., Vale, W. W., Rivier, J.E. and Thorner, M. O. (1989) Growth hormone response to growth hormone releasing factor in Alzheimer's disease. Neuroendocrinology 50, 663-666.
33. Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H. and Perry, R. H. (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Brit. Med. J. 267, 1457-1459.
34. Rossor, M. N., Iversen, L. L., Reynolds, G. P., Mountjoy, C. Q. and Roth, M. (1987) Neurochemical characteristics of early and late onset types of Alzheimer's disease. Brit. Med. J. 288, 961964.
35. Rudman, D. (1985) Growth hormone, body composition and aging. J. Am. Geriatr. Soc. 33, 800-805.
36. Saper, C. B. and German, D. C. (1987) Hypothalamic pathology in Alzheimer's disease. Neurosci. Lett. 74, 364-370.
37. Steardo, L., Tamminga, C. A., Barone, P., Foster, N., D'Urso, R., Ruggeri, S. and Chase, T. N. (1984) CSF somatostatin immunoreactivity and GH plasma levels in Alzheimer's disease. Neuroendocrinol. Lett. 6, 291-293.
38. Vecsei, L. and Widerlov, E. (1990) Effects of somatostatin-28 and some of its fragments and analogs on open-field behavior, barrel rotation, and shuttle box learning in rats. Psychoneuroendocrinology 15, 139-145.
39. Weber, S. J., Louis, R. B., Trombley, L., Bissette, G., Davies, P. and Davis, T. P. (1992) Metabolic halflife of somatostatin and peptidase activities are altered in Alzheimer's disease. J. Gerontol. 47, B18-B25.
40. Wilcock, G. K., Esiri, M. M., Bowen, D. M. and Smith, C. C. T. (1982) Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57, 407-417.